Cost-utility of tDCS in depression treatment

被引：0
|
作者：
Sauvaget, A. [1 ]
机构：
[1] Univ Nantes, Psychiat, Nantes, France
来源：
EUROPEAN PSYCHIATRY | 2023年 / 66卷
关键词：
D O I：
10.1192/j.eurpsy.2023.166
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
W0011
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [1] Cost-utility of brief psychological treatment for depression and anxiety
    Hakkaart-van Roijen, L
    van Straten, A
    Rutten, MAF
    Donker, M
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 323 - 329
  • [2] COST-UTILITY ANALYSIS OF MAINTENANCE TREATMENT FOR RECURRENT DEPRESSION
    KAMLET, MS
    PAUL, N
    GREENHOUSE, J
    KUPFER, D
    FRANK, E
    WADE, M
    [J]. CONTROLLED CLINICAL TRIALS, 1995, 16 (01): : 17 - 40
  • [3] Pindolol augmentation of paroxetine and compliance in the treatment of depression: A cost-utility analysis
    Tome, M
    Isaac, M
    [J]. QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 388 - 388
  • [4] COST-UTILITY ANALYSIS OF VORTIOXETINE FOR THE TREATMENT OF MAJOR DEPRESSION DISORDERS IN CHINA
    Liu, M.
    Chen, W.
    [J]. VALUE IN HEALTH, 2019, 22 : S686 - S686
  • [5] The cost-utility of screening for depression in primary care
    Valenstein, M
    Vijan, S
    Zeber, JE
    Boehm, K
    Buttar, A
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) : 345 - 360
  • [6] Cost-utility analysis in depression: The McSad utility measure for depression health states
    Bennett, KJ
    Torrance, GW
    Boyle, MH
    Guscott, R
    [J]. PSYCHIATRIC SERVICES, 2000, 51 (09) : 1171 - 1176
  • [7] COST-UTILITY OF MAINTENANCE TREATMENT OF RECURRENT DEPRESSION WITH SERTRALINE VERSUS EPISODIC TREATMENT WITH DOTHIEPIN
    HATZIANDREU, EJ
    BROWN, RE
    REVICKI, DA
    TURNER, R
    MARTINDALE, J
    LEVINE, S
    SIEGEL, JE
    [J]. PHARMACOECONOMICS, 1994, 5 (03) : 249 - 264
  • [8] Cost-utility analysis of transcranial direct current stimulation (tDCS) in non-treatment-resistant depression: the DISCO randomised controlled study protocol
    Sauvaget, Anne
    Lagalice, Lydie
    Schirr-Bonnans, Solene
    Volteau, Christelle
    Pere, Morgane
    Dert, Cecile
    Rivalland, Annabelle
    Tessier, Fabienne
    Lepage, Adeline
    Tostivint, Agathe
    Deschamps, Thibault
    Thomas-Ollivier, Veronique
    Robin, Alison
    Pineau, Noemie
    Cabelguen, Clemence
    Bukowski, Nicolas
    Guitteny, Marie
    Beslot, Auxane
    Simons, Luc
    Vanelle, Jean-Marie
    D'Urso, Giordano
    Bulteau, Samuel
    Riche, Valery-Pierre
    [J]. BMJ OPEN, 2020, 10 (01):
  • [9] Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
    Carla Rognoni
    Camilla Falivena
    Francesco Costa
    Patrizio Armeni
    [J]. PharmacoEconomics, 2023, 41 : 209 - 225
  • [10] Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
    Rognoni, Carla
    Falivena, Camilla
    Costa, Francesco
    Armeni, Patrizio
    [J]. PHARMACOECONOMICS, 2023, 41 (2) : 209 - 225
12345